Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese Scientists Clone First Cow To Produce Anti-Cancer Proteins

This article was originally published in PharmAsia News

Executive Summary

Researchers in China say they have cloned the country's first cow specifically to produce CD20 antibodies in milk to treat cancer. The genetically modified cow was born Aug. 2, the researchers said, and another dozen are expected to be born in September. The plan calls for mass-breeding the cows to give China the ability to mass-produce the cancer-fighting proteins at a relatively low price. One of the researchers said the cloned cow was "very healthy" 10 days after birth. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts